Phase 4 Field Trial of the Unicirc Instrument With Tissue Adhesive (Unicirc003)

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2014 by Simunye Primary Health Care
Information provided by (Responsible Party):
Peter Millard, Simunye Primary Health Care Identifier:
First received: March 14, 2014
Last updated: March 17, 2014
Last verified: March 2014

This is a field trial of the Unicirc instrument to excise the foreskin, plus use of cyanoacrylate tissue adhesive to seal the wound.

Condition Intervention
Male Circumcision
Procedure: Unicirc instrument plus cyanoacrylate tissue adhesive
Device: Unicirc instrument

Study Type: Interventional
Study Design: Endpoint Classification: Safety Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: Phase 4 Field Trial of the Unicirc Instrument With Tissue Adhesive

Further study details as provided by Simunye Primary Health Care:

Primary Outcome Measures:
  • Intraoperative bleeding [ Time Frame: 1 hour ] [ Designated as safety issue: Yes ]
    Intraoperative bleeding requiring suture

  • Post operative bleeding [ Time Frame: 4 weeks ] [ Designated as safety issue: Yes ]
    Any bleeding (minor or requiring treatment) that occurs in the first 4 weeks post intervention

Secondary Outcome Measures:
  • Infection [ Time Frame: 4 weeks ] [ Designated as safety issue: Yes ]
    Post-op infection --minor (no treatment), moderate (requires antibiotics)

  • Wound dehiscence [ Time Frame: 4 weeks ] [ Designated as safety issue: Yes ]
    Wound separation caused by adhesive failure (minor --requires no treatment)

  • Any other adverse event [ Time Frame: 4 weeks ] [ Designated as safety issue: Yes ]
    Any other adverse event (pain, poor cosmetic result, other intraop or postop complication)

Estimated Enrollment: 100
Study Start Date: March 2014
Estimated Study Completion Date: June 2014
Estimated Primary Completion Date: May 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Unicirc with tissue adhesive
Circumcision with Unicirc instrument, followed by wound sealing with cyanoacrylate
Procedure: Unicirc instrument plus cyanoacrylate tissue adhesive
Volunteers will be circumcised using the Unicirc surgical instrument and the incision will be sealed using cyanoacrylate tissue adhesive
Other Names:
  • Unicirc
  • Cyanoacrylate
Device: Unicirc instrument


Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Men at least 18 years of age

Exclusion Criteria:

  • Poor general health
  • Anatomical abnormalities that would complicate circumcision
  • Bleeding disorder
  • Ongoing infection
  • Cannot attend followup visits
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT02091726

Contact: Peter S Millard, MD, PhD +1-207-299-2131
Contact: Cyril Parker, MD

South Africa
Simunye Primary Healthcare Recruiting
Cape Town, Western Cape, South Africa
Contact: Cyril Parker, MD         
Principal Investigator: Norman Goldstuck, MD         
Sponsors and Collaborators
Simunye Primary Health Care
Study Director: Norman Goldstuck, MD Department of Obstetrics and Gynaecology, Tygerberg Hospital, Cape Town, South Africa
  More Information

No publications provided

Responsible Party: Peter Millard, PI, Simunye Primary Health Care Identifier: NCT02091726     History of Changes
Other Study ID Numbers: Unicirc 003
Study First Received: March 14, 2014
Last Updated: March 17, 2014
Health Authority: South Africa: Human Research Ethics Committee

Keywords provided by Simunye Primary Health Care:
HIV prevention
Surgical device
Tissue Adhesive
voluntary processed this record on October 20, 2014